scholarly journals CYTOLOGICAL EVALUATION OF MALE BREAST LESIONS IN GREATER GWALIOR : A FIVE YEAR RETROSPECTIVE STUDY

2015 ◽  
Vol 2 (10) ◽  
pp. 1359-1364 ◽  
Author(s):  
Jagannath Jatav ◽  
Rajesh Gaur ◽  
Vidyanand Pandit ◽  
Bharat Jain
2021 ◽  
Vol 17 (2) ◽  
pp. 103-111
Author(s):  
Krishnendu Mondal ◽  
Rupali Mandal

2020 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Krishnendu Mondal ◽  
Rupali Mandal

2014 ◽  
Vol 8 (4) ◽  
pp. 511-515
Author(s):  
Manas Kotepui ◽  
Duangjai Piwkham ◽  
Chaowanee Chupeerach ◽  
Apiram Songsri

Abstract Background: Gynecomastia is a common benign lesion of the male breast and accounts for up to 80% of male patients referred with beast lesions. Objective: To examine the pattern of breast lesions in male patients who underwent breast biopsy. Methods: All male patients referred to Hatyai Hospital with breast complaints were included in the study. Histopathology reports were retrospectively reviewed during 2004-2011. Results: In 77 male patients diagnosed with breast lesions, the most common lesion was gynecomastia (49/77, 64%), followed by fibrocystic changes (7/77, 9%), and breast cancer (6/77, 8%). Gynecomastia was commonly found in male patients less than 40 years of age, while other breast lesions are seen in male patients over 40 years of age (P = 0.036, OR = 2.842, 95% CI = 1.085-7.447). Conclusion: Gynecomastia was the most common diagnosis among breast lesions in male patients referred to the Hatyai Hospital during 2004-2011. Gynecomastia was more common in the patients less than 20 years old.


2020 ◽  
pp. 1-8
Author(s):  
Melissa Oosthuizen ◽  
Rubina Razack ◽  
Jenny Edge ◽  
Pawel Tomasz Schubert

<b><i>Objective:</i></b> This study aims to determine the diagnostic utility of the International Academy of Cytology (IAC) Yokohama System for reporting breast cytopathology in lesions of the male breast. <b><i>Study Design:</i></b> Fine-needle aspiration biopsy (FNAB) reports between 2015 and 2019 were retrospectively recategorized according to the 5-tiered IAC Yokohama Reporting System. Our database yielded a total of 1,532 FNAB reports from breast lesions, obtained from 1,350 male patients. The risk of malignancy (ROM) and diagnostic performance of FNAB were determined using follow-up histopathological diagnosis and/or clinical follow-up, where available, for each category. <b><i>Results:</i></b> The category distribution were as follows: inadequate, 40%; benign, 57%; atypical, 0.6%; suspicious for malignancy, 0.7%; and malignant, 1.6%. The ROM in each category was nondiagnostic, 11%; benign, 3%; atypical, 28%; suspicious for malignancy, 56%; and malignant, 100%. The sensitivity, specificity, positive predictive value, and negative predictive value were recorded as 63, 100, 100, and 84.6% respectively, when only malignant cases were considered as positive tests. <b><i>Conclusion:</i></b> This study validates the IAC Yokohama System for reporting male breast cytopathology. In accordance with the aim of the Yokohama System to establish best practice guidelines for reporting breast cytopathology, this comprehensive scheme facilitates comparisons between local and international institutions. The ROM acts as an internal audit for quality assurance within one’s own laboratory and provides guidance for clinical management. It highlights inefficiencies such as high inadequacy rates for category 1 and also features strengths with impressive specificity for categories 4 and 5.


2010 ◽  
Vol 54 (3) ◽  
pp. 259-264 ◽  
Author(s):  
Carla A.P. Wauters ◽  
Bauke W. Kooistra ◽  
Ineke M. de Kievit-van der Heijden ◽  
Luc J.A. Strobbe

Author(s):  
Puay Hoon Tan ◽  
Aysegul A. Sahin
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document